Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
Synopsis
Prioritise evidence-based cancer prevention, communicate absolute rather than exaggerated risk, and connect tobacco, alcohol, weight, infection, ultraviolet and occupational interventions to equitable care.
Tobacco avoidance and cessation remains the highest-impact modifiable cancer-prevention intervention and reduces cardiovascular and respiratory harm at the same time.
Alcohol risk rises with consumption and affects several cancer sites; practical reduction advice should avoid implying that any drinking level is cancer-protective.
Maintaining a healthy weight, regular activity and a fibre-rich diet support prevention, but counselling must avoid blame because cancer is multifactorial.
Investigation priorities
01
Structured tobacco assessmentFirst step
Measure current use, dependence, previous quit attempts and readiness.
Management branches
PrioritiseChoose the highest-value change
A routine consultation identifies several potentially modifiable exposures.
Address tobacco first when present, while also identifying alcohol dependence, safeguarding, occupational hazards or symptoms that cannot wait.
Use shared decision-making to select a feasible action and explain the expected broader health benefit without promising cancer prevention.
Key medicines
Varenicline for tobacco dependenceStart 1–2 weeks before the quit date: 0.5 mg orally once daily on days 1–3, 0.5 mg twice daily on days 4–7, then 1 mg twice daily from day 8, usually for 12 weeks; reduce for intolerance and follow the SmPC for severe renal impairment.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.
NHS England cancer programmeNational prevention, earlier diagnosis and inequality-reduction priorities across cancer pathways.
NHS screening overviewCurrent NHS overview of screening, invitations, benefits, limitations and the need to investigate symptoms separately.